Vimarsana
Biggest News Aggregation in the World

Pharma Co Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Co Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Co Ltd Today - Breaking & Trending Today

Cassava Starch Market Set to Cross US$ 6.78 Billion at 4.9% - Vimarsana News

Cassava Starch Market Set to Cross US$ 6.78 Billion at 4.9%

Growing Demand for Functional Foods with Nutritional and Health Benefits Driving Cassava Starch Market Expansion...

Neurotrophic Keratitis Treatment Market Aims for US$ 10 Billion Valuation by 2033 | Future Market In - Vimarsana News

Neurotrophic Keratitis Treatment Market Aims for US$ 10 Billion Valuation by 2033 | Future Market In

The global neurotrophic keratitis treatment market is on a trajectory of impressive growth, with a projected valuation of US$ 5 billion in 2023. According to a recent report by Future Market Insights, the market is expected to maintain a robust Compound Annual Growth Rate (CAGR) of 7.17% until 2033, eventually reach...

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics - Vimarsana News

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics

/PRNewswire/ -- The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029"...

Taiwan's FDA recalls mouthwash, ointments - Vimarsana News

Taiwan's FDA recalls mouthwash, ointments

Taipei, July 4 (CNA) A brand of mouthwash and two types of ointments are in the process of being recalled as they have either been found to contain impurities exceeding the allowed standard or inconsistent amounts of the main ingredients, according to the Taiwan Food and Drug Administration (FDA) on Monday.

Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business Amendment in relation to a return of domestic marketing rights for a product - Vimarsana News

Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business Amendment in relation to a return of domestic marketing rights for a product

TOKYO, March 22, 2022 — FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) has announced an amendment of certain part of the share transfer agreement with PeptiDream Inc.